NORTH CHICAGO, Ill., Sept. 30, 2024 /PRNewswire/ — U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has earned an NIH fast-track grant for the development of a novel treatment for a deadly form of brain cancer. The $500,000 award for Year 1 of…